Are we negating the benefits of CABG by forgetting secondary prevention?

P. R. Belcher, A. Gaw, M. Cooper, M. Brown, D. J. Wheatley, Grace M. Lindsay

Research output: Contribution to journalArticle

Abstract

In this prospective observational study, we examined the prescription of anti-anginal drugs preoperatively compared to at one year after operation and the extent to which medically managed secondary prevention measures, including control of hypertension and hyperlipidaemia, were achieved in this patient group.

Original languageEnglish
JournalJournal of Human Hypertension
DOIs
Publication statusPublished - 1 Oct 2002

Keywords

  • coronary
  • hypertension
  • surgery

Fingerprint Dive into the research topics of 'Are we negating the benefits of CABG by forgetting secondary prevention?'. Together they form a unique fingerprint.

  • Cite this

    Belcher, P. R., Gaw, A., Cooper, M., Brown, M., Wheatley, D. J., & Lindsay, G. M. (2002). Are we negating the benefits of CABG by forgetting secondary prevention? Journal of Human Hypertension. https://doi.org/10.1038/sj.jhh.1001469